Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Baxter to make Moderna COVID-19 vaccine in US

By Chris Newmarker | March 9, 2021

Baxter ModernaBaxter announced that its Baxter BioPharma Solutions business will make Moderna‘s COVID-19 vaccine at its fill/finish sterile manufacturing facilities in Bloomington, Ind.

The plan — announced yesterday — is for Baxter to make 60–90 million doses of the Moderna vaccine in 2021.

“We have seen a remarkable demonstration of scientific and health care expertise in the effort to develop vaccines for COVID-19,” said Marie Keeley, VP of Baxter BioPharma Solutions.

“Baxter is honored to provide our deep expertise in vaccine manufacturing to help partners like Moderna bolster the supply of their vaccine,” Keeley said in a news release.

Baxter’s 600,000 ft2, 700-employee campus in Bloomington has capabilities and expertise in parenteral delivery systems and clinical and commercial vaccine manufacturing — including preventive and seasonal vaccines for global markets.

The major COVID-19 vaccine makers have been making a host of manufacturing outsourcing deals — sometimes with competitors — as they seek to ramp up production enough to meet U.S. and worldwide goals to reach herd immunity against the novel, potentially deadly coronavirus.

“This additional production will help us continue to scale up our manufacturing capacity in the United States,” Moderna CTO Juan Andres said of the deal with Baxter.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Wuxi AppTec
WuXi STA constructing manufacturing facility in Middletown, Delaware
analyzing medical sample
Expert answers to nitrosamine impurity questions
Touchlight
Touchlight inks patent license deal with Pfizer related to the use of dbDNA in mRNA products
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards